There is evidence for the shift of regulatory setpoints of functionall
y linked neurotransmitter systems as a basis of psychiatric disorders.
C-11-raclopride PET, which has been shown to be sensitive to changes
in endogenous dopamine and has a high short-term test-retest reliabili
ty, can be used to investigate different regulatory states of the dopa
minergic system with respect to psychiatric diseases and pharmacologic
al influences. Prior to these studies, the reliability of the method o
ver time has to be established. The current study was performed in ord
er to evaluate the long-term stability of the striatal dopaminergic sy
stem. Eight normal healthy subjects (mean age: 48.1 years; range: 24-7
5) were studied twice with C-11-raclopride PET two times under resting
conditions with a mean time interval between the scans of 11.3 months
(range: 1-19). The ratio of basal ganglia (BG) to cerebellar (CB) dis
tribution volumes (DVs) revealed a mean absolute change of 6.94 (range
: 0.0-12.87%) between study A and B. BG DVs mean absolute change was 6
.30% (range: 0.55-30.46%), CB DVs mean absolute change was 8.65% (rang
e: 3.51-16.33%). The mean change of the BG/CB ratio was -0.33% (range:
12.87-12.34%). BG DVs mean change was 4.55% (range: 4.2-30.46%), CB D
Vs mean change was 5.10% (range: -10.71-16.33%). The intraindividual d
ifferences between the two scans in our study were not significantly d
ifferent as compared to the 24 hour interval test-retest data, which h
ave been published earlier (repeated measures ANOVA with df = 11; F =
0.49; P = 0.50) [Volkow et al. (1993) J. Nucl. Med., 34:609-613]. The
intraclass correlation of the DV ratio index was r = 0.81. The binding
potential in the baseline scans and repeated scans showed a non-signi
ficant correlation with age (r = -0.58, P = 0.13). Interindividually,
the DV ratio index revealed a mean of 3.18 (range = 2.55-3.68, SD = 0.
42 in study A and of 3.16 (range 2.37-3.57, SD = 0.41) in study B. The
intrasubject stability of the C-11-raclopride binding over a long-ter
m period in normal human subjects suggests the feasibility of study de
signs investigating the long-term changes of the dopaminergic responsi
vity after pharmacological challenges. The baseline stability will als
o serve as a necessary reference for further dose-response studies and
investigations of subchronical pharmacological interventions. (C) 199
8 Wiley-Liss, Inc.